SR protein expression and CD44 splicing pattern in human breast tumours

Breast Cancer Research and Treatment

Volumn 79, Issue 1, 2003, Pages 75-82

  Pind, Molly T ^a   Watson, Peter H ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Breast cancer; CD44 variants; SR proteins

Indexed keywords

HERMES ANTIGEN; ISOPROTEIN; MESSENGER RNA; PHOSPHOPROTEIN; PROTEIN SR30; PROTEIN SR40; PROTEIN SR55; PROTEIN SR75; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GRADING; CANCER SIZE; CELL STRAIN MCF 7; COHORT ANALYSIS; CONTROLLED STUDY; EXON; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INVASIVE CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; WESTERN BLOTTING;

ALTERNATIVE SPLICING; ANTIGENS, CD44; BREAST NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEIN ISOFORMS; RNA, MESSENGER; RNA-BINDING PROTEINS; TUMOR CELLS, CULTURED;

EID: 0038027029     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023338718974     Document Type: Article

References (34)

1. Murphy LC, Dotzlaw H, Leygue E, Courts A, Watson P: The pathophysiological role of estrogen receptor variants in human breast cancer. J Steroid Biochem Mol Biol 65: 175-180, 1998
2. Huang A, Leygue E, Dotzlaw H, Murphy LC, Watson PH: Influence of estrogen receptor variants on the determination of ER status in human breast cancer. Breast Cancer Res Treat 58: 219-225, 1999
3. Hole AK, Belkhiri A, Snell LS, Watson PH: CD44 variant expression and estrogen receptor status in breast cancer. Breast Cancer Res Treat 43: 165-173, 1997
4. Wang C, Thor AD, Moore DH, Zhao Y, Kerschmann R, Stern R, Watson PH, Turley EA: The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin Cancer Res 4: 567-576, 1998
5. Sharp PA: RNA splicing and genes. JAMA 260: 3035-3041, 1988
6. Hastings ML, Krainer AR: Pre-mRNA splicing in the new millennium. Curr Opin Cell Biol 13: 302-309, 2001
7. Fu XD, Maniatis T: Isolation of a complementary DNA that encodes the mammalian splicing factor SC35. Science 256: 535-538, 1992
8. Screaton GR, Caceres JF, Mayeda A, Bell MV, Plebanski M, Jackson DG, Bell JI, Krainer AR: Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J 14: 4336-4349, 1995
9. Graveley BR: Sorting out the complexity of SR protein functions. RNA 6: 1197-1211, 2000
10. Manley JL, Tacke R: SR proteins and splicing control. Genes Dev 10: 1569-1579, 1996
11. Zahler AM, Neugebauer KM, Lane WS, Roth MB: Distinct functions of SR proteins in alternative pre-mRNA splicing. Science 260: 219-222, 1993
12. Hofmann M, Rudy W, Zoller M, Tolg C, Ponta H, Herrlich P, Gunthert U: CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 51: 5292-5297, 1991
13. Hiller T, Snell L, Watson PH: Microdissection RT-PCR analysis of gene expression in pathologically defined frozen tissue sections. Biotechniques 21: 38-40, 42, 44, 1996
14. Watson PH, Snell L, Parisien M: The NCIC-Manitoba Breast Tumor Bank: a resource for applied cancer research. CMAJ 155: 281-283, 1996
15. Schagger H, von Jagow G: Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100kDa. Anal Biochem 166: 368-379, 1987
16. Tanaka M, Herr W: Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell 60: 375-386, 1990
17. Gunthert U: CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 184: 47-63, 1993
18. Zahler AM, Lane WS, Stolk JA, Roth MB: SR proteins: a conserved family of pre-mRNA splicing factors. Genes Dev 6: 837-847, 1992
19. Murphy LC, Leygue E, Dotzlaw H, Douglas D, Coutts A, Watson PH: Oestrogen receptor variants and mutations in human breast cancer. Ann Med 29: 221-234, 1997
20. Leygue E, Dotzlaw H, Watson PH, Murphy LC: Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue. Cancer Res 59: 1175-1179, 1999
21. Leygue E, Dotzlaw H, Watson PH, Murphy LC: Altered expression of exon 6 deleted progesterone receptor variant mRNA between normal human breast and breast tumour tissues. Br J Cancer 80: 379-382, 1999
22. Sanford JR, Bruzik JP: Developmental regulation of SR protein phosphorylation and activity. Genes Dev 13: 1513-1518, 1999
23. Gui JF, Lane WS, Fu XD: A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature 369: 678-682, 1994
24. Stickeler E, Kittrell F, Medina D, Berget SM: Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 18: 3574-3582, 1999
25. Ghigna C, Moroni M, Porta C, Riva S, Biamonti G: Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. Cancer Res 58: 5818-5824, 1998
26. Bell MV, Cowper AE, Lefranc MP, Bell JI, Screaton GR: Influence of intron length on alternative splicing of CD44. Mol Cell Biol 18: 5930-5941, 1998
27. Graveley BR, Hertel KJ, Maniatis T: A systematic analysis of the factors that determine the strength of pre-mRNA splicing enhancers. EMBO J 17: 6747-6756, 1998
28. Schaal TD, Maniatis T: Selection and characterization of pre-mRNA splicing enhancers: identification of novel SR protein-specific enhancer sequences. Mol Cell Biol 19: 1705-1719, 1999
29. Cowper AE, Caceres JF, Mayeda A, Screaton GR: Serine-arginine (SR) protein-like factors that antagonize authentic SR proteins and regulate alternative splicing. J Biol Chem 276: 48908-48914, 2001
30. Du C, McGuffin ME, Dauwalder B, Rabinow L, Mattox W: Protein phosphorylation plays an essential role in the regulation of alternative splicing and sex determination in Drosophila. Mol Cell 2: 741-750, 1998
31. Xiao SH, Manley JL: Phospborylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev 11: 334-344, 1997
32. Nayler O, Stamm S, Ullrich A: Characterization and comparison of four serine- and arginine-rich (SR) protein kinases. Biochem J 326(Pt 3): 693-700, 1997
33. Rossi F, Labourier E, Forne T, Divita G, Derancourt J, Riou JF, Antoine E, Cathala G, Brunel C, Tazi J: Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature 381: 80-82, 1996
34. Misteli T, Spector DL: Serine/threonine phosphatase 1 modulates the subnuclear distribution of pre-mRNA splicing factors. Mol Biol Cell 7: 1559-1572, 1996